Scilex Holding Company (NASDAQ: SCLX) is a small cap NASDAQ firm that is an innovative leader in non-opioid pain therapeutics. The company's offerings could significantly aid in stopping the opioid crisis and create maximum shareholder growth!
PLUS, SCLX has been heavily shorted. Based off of Ortex.com, as of November 1st, 2024, the short interest for SCLX on the Nasdaq was at $12.2M in value with 12.71M shares shorted. There are 22.35M shares on loan. A short squeeze could be imminent! What is a short squeeze and why does it matter? This is a situation in which the price of a stock rises to such an extent that investors who have sold short, have to quickly purchase the stock in order to limit their losses. Zacks Small Cap Research is BULLish on the company and believes that "SCLX is poised to resume its move higher and that investors continue to underestimate the value of the treatments the company currently has and is developing." Zacks SCR has a $5.50 price target on the stock!
|
Tuesday 5 November 2024
SCLX is a NASDAQ traded stock with a BIG short position.
Subscribe to:
Post Comments (Atom)
Get Covered in the Market BEFORE the election shakeup
Join THIS FREE, LIVE briefing on Nov. 6th to navigate the post-election market. Are you ready for the elec...
-
AllBusiness.com Trump Finally Signs the Relief Act—10 Important Things You Need to Know Posted: 27 ...
-
Job Alert Shop Insurance Defense Attorney- Metairie Master Trend Forex Trading System….Getting Started ...
-
Job Alert Shop FEDISA – Junior Lecturer – Pattern & Garment Technology 2021 Pre-Primary & Primar...
No comments:
Post a Comment